Skip to main content

Table 3 All-cause and cardiovascular mortality among U.S. Elders, NHANES III (1988–1994)

From: Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

Mortality outcome by age group No. of subjects No. of deaths Cumulative mortality (%) 5-year Mortality aHR (95% CI) 10-year Mortality aHR (95% CI) Cumulative mortality aHR (95% CI)
All-cause
 Aged 60–74
  No NAFLD 1122 643 54.02 Reference Reference Reference
  NAFLD 973 625 66.23* 1.60 (1.24–1.96) 1.22 (1.01–1.49) 1.23 (1.07–1.42)
 Aged 75 +   1112     
  No NAFLD 715 675 92.21 Reference Reference Reference
  NAFLD 461 437 94.20 1.11 (0.88–1.40) 1.17 (0.99–1.36) 1.12 (0.97–1.29)
Cardiovascular disease
 Aged 60–74
  No NAFLD 917 201 15.71 Reference Reference Reference
  NAFLD 772 188 20.46* 2.12 (1.20–3.75) 1.06 (0.73–1.52) 1.20 (0.95–1.52)
 Aged 75 +
  No NAFLD 707 260 34.96 Reference Reference Reference
  NAFLD 458 175 36.36 1.05 (0.76–1.44) 1.13 (0.89–1.42) 1.07 (0.90–1.26)
  1. NAFLD was defined as a US FLI score of ≥ 30 in the absence of any other cause of chronic liver disease
  2. Multivariate models were adjusted for male, current smoker, hypertension, hyperlipidemia, advance fibrosis (NFS > .676), and history of CVD and cancer. Age, race, diabetes were not considered because of components of US FLI score
  3. *Significantly different from No NAFLD (p < .05)
  4. †p < .05
  5. abbreviation: CI confidence interval, aHR adjusted Hazard Ratios